- Home
- PLRX vs ORC Comparison
PLRX vs ORC Comparison
Compare PLRX & ORC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | ORC |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 1.2B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | PLRX | ORC |
|---|---|---|
| Price | $1.30 | $7.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $3.79 | ★ $7.50 |
| AVG Volume (30 Days) | 955.4K | ★ 6.5M |
| Earning Date | 03-02-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 18.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $80,187,000.00 |
| Revenue This Year | N/A | $90.64 |
| Revenue Next Year | N/A | $78.88 |
| P/E Ratio | ★ N/A | $13.52 |
| Revenue Growth | N/A | ★ 5.93 |
| 52 Week Low | $1.10 | $5.69 |
| 52 Week High | $12.88 | $9.01 |
Technical Indicators
Market Signals| Indicator | PLRX | ORC |
|---|---|---|
| Relative Strength Index (RSI) | 47.62 | 71.69 |
| Support Level | $1.28 | $7.15 |
| Resistance Level | $1.38 | $7.59 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 55.26 | 94.70 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About ORC Orchid Island Capital Inc.
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.